The case for compulsory licensing during Covid-19
Bibliographic Data
| ID | 19551607 |
|---|---|
| Authors | Hilary Wong (0000-0003-4597-1794, University of California, Berkeley, corresponding author) |
| Year | 2020 |
| Volume | 10 |
| Issue | 1 |
| Pages | 010358-010358 |
| Publication date | 2020-06-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Global Health (JOURNAL) |
| Journal identifiers | ISSN: 2047-2978 • E-ISSN: 2047-2986 |
| Publisher | International Society of Global Health (PUBLISHER • GB) |
| DOI | 10.7189/jogh.10.010358 |
| PMID | 32509289 |
| OpenAlex | W3026409591 |
| Language | EN |
| Citations received | 5 |
| References cited | 4 |
The amendment allows the government to issue a
2019-20 coronavirus outbreak · Betacoronavirus · Coronavirus Infections · Government regulation · MEDLINE · Political science · Law · Medical Malpractice and Liability Issues · Medicine · Occupational and Professional Licensing Regulation · Virology
Analysing the interplay between the right to health and pharmaceutical patent rights in the introduction of a Covid-19 vaccine into the Philippines
Barriers to Covid-19 Health Products in Low-and Middle-Income Countries During the Covid-19 Pandemic
Compulsory licensing of pharmaceuticals during public health crisis
Covid-19 vaccines pricing policy options for low-income and middle- income countries
The role of patent waivers and compulsory licensing in facilitating access to Covid-19 vaccines
| Citations per year | 1 |
|---|---|
| Citation span | 2021 - 2025 (5) |
| Highly cited | No |